Concomitant fibromyalgia in primary Sjögren's ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Concomitant fibromyalgia in primary Sjögren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
Author(s) :
Dubost, Jean-Jacques [Auteur]
CHU Gabriel Montpied [Clermont-Ferrand]
Couderc, Marion [Auteur]
Université de Montpellier [UM]
Pereira, Bruno [Auteur]
Unité de Biostatistiques [CHU Clermont-Ferrand]
Mariette, Xavier [Auteur]
Immunologie des Maladies Virales et Autoimmunes [IMVA - U1184]
Seror, Raphaèle [Auteur]
Immunologie des Maladies Virales et Autoimmunes [IMVA - U1184]
Gottenberg, Jacques-Eric [Auteur]
Université de Strasbourg [UNISTRA]
Hachulla, Eric [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Centre National de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France [CeRAINO]
Le Guern, Veronique [Auteur]
Centre de référence des maladies auto-immunes systémiques rares d'Île-de-France / National Reference Center for Rare Systemic Autoimmune Diseases
Saraux, Alain [Auteur]
LabEX IGO Immunothérapie Grand Ouest
Lymphocytes B, Autoimmunité et Immunothérapies [LBAI]
Morel, Jacques [Auteur]
Hôpital Lapeyronie [Montpellier] [CHU]
Salliot, Carine [Auteur]
Centre Hospitalier Régional d'Orléans [CHRO]
Tournadre, Anne [Auteur]
CHU Gabriel Montpied [Clermont-Ferrand]
Soubrier, Martin [Auteur]
Université Clermont Auvergne [2017-2020] [UCA [2017-2020]]
CHU Gabriel Montpied [Clermont-Ferrand]
Couderc, Marion [Auteur]
Université de Montpellier [UM]
Pereira, Bruno [Auteur]
Unité de Biostatistiques [CHU Clermont-Ferrand]
Mariette, Xavier [Auteur]
Immunologie des Maladies Virales et Autoimmunes [IMVA - U1184]
Seror, Raphaèle [Auteur]
Immunologie des Maladies Virales et Autoimmunes [IMVA - U1184]
Gottenberg, Jacques-Eric [Auteur]
Université de Strasbourg [UNISTRA]
Hachulla, Eric [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Centre National de Référence des Maladies Auto-Immunes Systémiques Rares du Nord et Nord-Ouest de France [CeRAINO]
Le Guern, Veronique [Auteur]
Centre de référence des maladies auto-immunes systémiques rares d'Île-de-France / National Reference Center for Rare Systemic Autoimmune Diseases
Saraux, Alain [Auteur]
LabEX IGO Immunothérapie Grand Ouest
Lymphocytes B, Autoimmunité et Immunothérapies [LBAI]
Morel, Jacques [Auteur]
Hôpital Lapeyronie [Montpellier] [CHU]
Salliot, Carine [Auteur]
Centre Hospitalier Régional d'Orléans [CHRO]
Tournadre, Anne [Auteur]
CHU Gabriel Montpied [Clermont-Ferrand]
Soubrier, Martin [Auteur]
Université Clermont Auvergne [2017-2020] [UCA [2017-2020]]
Journal title :
Clinical and experimental rheumatology
Abbreviated title :
Clin Exp Rheumatol
Volume number :
39
Pages :
140-145
Publication date :
2021-12-21
ISSN :
0392-856X
English keyword(s) :
primary Sjogren's syndrome
fibromyalgia
questionnaire
fibromyalgia
questionnaire
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
OBJECTIVES:
Dryness, fatigue, and pain are classic symptoms in primary Sjögren’s syndrome (pSS) but are also common in fibromyalgia (FM). We compared the characteristics of FM assessed by different criteria (American ...
Show more >OBJECTIVES: Dryness, fatigue, and pain are classic symptoms in primary Sjögren’s syndrome (pSS) but are also common in fibromyalgia (FM). We compared the characteristics of FM assessed by different criteria (American College of Rheumatology (ACR) 2016 and 1990 criteria), physician’s opinion and Fibromyalgia Rapid Screening Tool (FiRST) questionnaire) in a cohort of patients with pSS. METHODS: Eight hospital departments tested 134 patients with pSS according to AECG criteria from the Assessment of Systemic Signs and Evolution in Sjögren’s Syndrome (ASSESS) cohort. RESUKLTS: FM was present in 19%, 18%, 20%, and 29% of cases according to ACR 2016, ACR 1990 criteria, physician’s opinion and the FiRST questionnaire, respectively. FM criteria-positive patients had higher EULAR SS Patient-Reported Index (ESSPRI) score, but not higher EULAR SS Disease Activity Index (ESSDAI) score. The objective measurements of dryness and the use of corticosteroids and immunosuppressive drugs did not differ between FM positive and negative patients. Regarding the ESSPRI dryness and fatigue subscale scores, depression and anxiety scores and the use of anxiolytics and antidepressants, the FiRST questionnaire exhibited a higher difference between positive and negative patients than ACR 2016 criteria. ACR 1990 and physician’s opinion were somewhere in the middle. ACR 2016 exhibited moderate agreement with ACR 1990 (κ=0.52) and the physician’s opinion (κ=0.60) and poor agreement with FiRST (κ=0.39). CONCLUSIONS: The FM criteria identified pSS patients with higher ESSPRI scores but not higher ESSDAI systemic disease scores. Agreement between the different FM criteria was moderate, and the characteristics they described did not fully coincide.Show less >
Show more >OBJECTIVES: Dryness, fatigue, and pain are classic symptoms in primary Sjögren’s syndrome (pSS) but are also common in fibromyalgia (FM). We compared the characteristics of FM assessed by different criteria (American College of Rheumatology (ACR) 2016 and 1990 criteria), physician’s opinion and Fibromyalgia Rapid Screening Tool (FiRST) questionnaire) in a cohort of patients with pSS. METHODS: Eight hospital departments tested 134 patients with pSS according to AECG criteria from the Assessment of Systemic Signs and Evolution in Sjögren’s Syndrome (ASSESS) cohort. RESUKLTS: FM was present in 19%, 18%, 20%, and 29% of cases according to ACR 2016, ACR 1990 criteria, physician’s opinion and the FiRST questionnaire, respectively. FM criteria-positive patients had higher EULAR SS Patient-Reported Index (ESSPRI) score, but not higher EULAR SS Disease Activity Index (ESSDAI) score. The objective measurements of dryness and the use of corticosteroids and immunosuppressive drugs did not differ between FM positive and negative patients. Regarding the ESSPRI dryness and fatigue subscale scores, depression and anxiety scores and the use of anxiolytics and antidepressants, the FiRST questionnaire exhibited a higher difference between positive and negative patients than ACR 2016 criteria. ACR 1990 and physician’s opinion were somewhere in the middle. ACR 2016 exhibited moderate agreement with ACR 1990 (κ=0.52) and the physician’s opinion (κ=0.60) and poor agreement with FiRST (κ=0.39). CONCLUSIONS: The FM criteria identified pSS patients with higher ESSPRI scores but not higher ESSDAI systemic disease scores. Agreement between the different FM criteria was moderate, and the characteristics they described did not fully coincide.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Submission date :
2024-01-12T05:27:05Z
2024-01-31T10:30:03Z
2024-04-16T07:18:13Z
2024-01-31T10:30:03Z
2024-04-16T07:18:13Z